Allen Buxton
Impact in
Papers in
-
- Sarcoma Diagnosis and Treatment 11
- Neurology 16
- Neuroblastoma Research and Treatments 14
- Co-authors
- Katherine K. Matthay (3 shared papers)C. Patrick Reynolds (3 shared papers)Wendy B. London (4 shared papers)Robert C. Seeger (3 shared papers)John M. Maris (3 shared papers)Susan L. Cohn (4 shared papers)Alice L. Yu (3 shared papers)Stephan A. Grupp (2 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Neuro-Oncology (6 papers)Pediatric Blood & Cancer (6 papers)Blood (3 papers)Cancer (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Allen Buxton
47 papers receiving 3.1k citations
Allen Buxton's Hit Papers
Peers
Comparison fields: 5 of 89
- Neurology 1.8k
- Genetics 685
- Oncology 977
- Cancer Research 528
- Hematology 276
Countries citing papers authored by Allen Buxton
This map shows the geographic impact of Allen Buxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Buxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Buxton more than expected).
Fields of papers citing papers by Allen Buxton
This network shows the impact of papers produced by Allen Buxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Buxton. The network helps show where Allen Buxton may publish in the future.
Co-authors
The 25 scholars most cited alongside Allen Buxton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma Hit paper breakdown → | 2010 | 1233 |
| 2 | 2011 | 260 | |
| 3 | 2013 | 211 | |
| 4 | 2010 | 184 | |
| 5 | 2014 | 157 | |
| 6 | 2015 | 107 | |
| 7 | 2003 | 105 | |
| 8 | 2016 | 102 | |
| 9 | 2009 | 83 | |
| 10 | 2012 | 67 | |
| 11 | 2003 | 60 | |
| 12 | 2011 | 54 | |
| 13 | 2019 | 52 | |
| 14 | 2021 | 39 | |
| 15 | 2016 | 38 | |
| 16 | 2018 | 32 | |
| 17 | 2011 | 31 | |
| 18 | 2005 | 31 | |
| 19 | 2017 | 29 | |
| 20 | 2022 | 23 |
About Allen Buxton
Allen Buxton is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 49 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (14 papers), Sarcoma Diagnosis and Treatment (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Glioma Diagnosis and Treatment (8 papers), Childhood Cancer Survivors' Quality of Life (7 papers), Acute Myeloid Leukemia Research (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). The work is most often cited by research in Neurology (1.8k citations), Genetics (685 citations), Oncology (977 citations), Cancer Research (528 citations) and Hematology (276 citations). Allen Buxton has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Katherine K. Matthay, C. Patrick Reynolds, Wendy B. London, Robert C. Seeger, John M. Maris, Susan L. Cohn, Alice L. Yu, Stephan A. Grupp, Judith G. Villablanca and Susan G. Kreissman. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Pediatric Blood & Cancer, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.